Orient Biotech and its subsidiaries have obtained multiple medical device registration certificates

Zhitong
2025.08.18 07:43
portai
I'm PortAI, I can summarize articles.

Orient Biotech and its wholly-owned subsidiary, American Hengjian and Shanghai Wanzi Health Biotechnology, recently obtained multiple medical device registration certificates, including the Influenza A/B Virus Antigen Detection Kit, Anti-MPO Antibody Detection Kit, Anti-PR3 Antibody Detection Kit, Anti-GBM Antibody Detection Kit, Healgen® Immunofluorescence Analyzer (OG-H180), and Healgen® AccuFluor Fentanyl Fluorescence Immunoassay Test Kit

According to the Zhitong Finance APP, Orient Biotech (688298.SH) announced that the company and its wholly-owned subsidiary, American Hengjian and Shanghai Wanzi Health Bio, have recently obtained the following medical device registration certificates. The product names are: Influenza A/B Virus Antigen Detection Kit (Colloidal Gold Method) (Professional), Anti-MPO Antibody, Anti-PR3 Antibody, Anti-GBM Antibody Detection Kit (Flow Fluorescence Luminescence Method), Healgen® Immunofluorescence Analyzer (OG-H180), and Healgen® AccuFluor Fentanyl Fluorescence Immunoassay (FIA) Test Kit - Qualitative

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.